Company overview
Sphere Bio provides picodroplet microfluidic instruments, consumables, and reagents for high-throughput single cell analysis, isolation, and monoclonality assurance. Their flagship Cyto-Mine Chroma platform screens up to 40 million cells per day for applications in antibody discovery, cell line development, cell therapy, and synthetic biology. As a Fluidic Sciences brand, they support biopharma R&D with integrated workflows for rapid screening of viable, high-producing clones.
Sphere Bio is listed in the NovaPharmaNews Supplier Hub as a Life Science Reagents, CRO & Clinical Services partner serving United States & Americas. Core focus areas include single cell analysis, picodroplet microfluidics, cyto-mine chroma, cell isolation, antibody discovery.
Industry categories: Life Science Reagents, CRO & Clinical Services. These tags help R&D, manufacturing, and procurement teams discover vendors aligned with their pipeline stage and compliance requirements.
Products and technologies associated with Sphere Bio include Cro — relevant for pharmaceutical discovery, process development, and GMP manufacturing workflows.
Structured facts
- Website
- https://spherebio.com
- Categories
- Life Science Reagents, CRO & Clinical Services
- Markets served
- United States & Americas
- Keywords
- single cell analysis, picodroplet microfluidics, cyto-mine chroma, cell isolation, antibody discovery
Products & technologies
Therapeutic areas
Markets served
Industry categories
Company timeline
- — Profile published on NovaPharmaNews
- — Profile last updated
Related suppliers in category
Frequently asked questions
- What are Sphere Bio's key technologies and capabilities?
- Sphere Bio offers picodroplet microfluidic systems like Cyto-Mine Chroma for high-throughput single cell screening, analysis, isolation, imaging, and dispensing. These enable rapid assessment of productivity, viability, and monoclonality in applications such as antibody discovery and cell therapy.
- What applications do Sphere Bio's products support?
- Products support biopharmaceutical discovery, cell line development, cell therapy engineering, bioproduction, synthetic biology, and vaccine generation, screening up to 40 million cells per day.
- Where is Sphere Bio based and how to contact them?
- Sphere Bio is based in Cambridge, England. Contact Dr. Claire Cox at [email protected] or +44 (0)7365 209 441 for inquiries.
Related editorial coverage
- $2M Gene Therapy Cures Need a Financing Model
- A Secure And Intelligent Drug Delivery Model Integrating Neural Networks With Blockchain
- AACR 2024: Daily Oncology Research Roundup
- AACR 2024: Oncology News & Key Takeaways - Day 1
- AACR 2024: Oncology Research Highlights - Day 1 Roundup
- AACR 2026: AI Pathology & Oncolytic Virus Spark Interest
Explore lab tools and QA/QC resources for R&D teams.
